Biology of IGF-1 its interaction with insulin in health and malignant states /
"The clinical use of long-term growth hormone treatment is increasing and such treatment leads to raised IGF-1 levels. Increased insulin levels are also more common as the prevalence of insulin resistance, which frequently presages obesity and/or type 2 diabetes, increases in the population. Th...
Saved in:
Corporate Authors: | |
---|---|
Group Author: | ; |
Published: |
|
Literature type: | Electronic eBook |
Language: | English |
Series: |
Novartis Foundation symposium ;
262 |
Subjects: | |
Online Access: |
http://onlinelibrary.wiley.com/book/10.1002/0470869976 |
Summary: |
"The clinical use of long-term growth hormone treatment is increasing and such treatment leads to raised IGF-1 levels. Increased insulin levels are also more common as the prevalence of insulin resistance, which frequently presages obesity and/or type 2 diabetes, increases in the population. Therefore, a careful discussion of the role of IGF-1 and insulin in various cancers is urgently needed. This book examines these issues in detail. It features contributions from the leading scientists and clinicians in the field and should prove essential reading for anyone with a clinical interest in in |
Carrier Form: | 1 online resource (viii, 280 p.) : ill. |
Bibliography: | Includes bibliographical references and indexes. |
ISBN: |
0470869976 (electronic bk.) 9780470869970 (electronic bk.) |
Index Number: | QP552 |
CLC: | R362-532 |
Contents: | Circulating IGF-I and its role in cancer: lessons from the IGF-1 gene-deletion (LID) mouse -- Physiology of the IGF system -- Molecular basis of insulin action -- IGF-1 and insulin as growth hormones -- Insulin-like growth factors and neoplasia -- Loss of IGF2 imprinting: mechanisms and consequences -- Insulin and IGF-1 receptor trafficking and signalling -- The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb -- Structural biology of insulin and IGF-1 receptors -- Genetic blockade of the insulin-like growth factor-I receptor for human |